Homely leverer boligalarm tilknyttet døgnåpen, FG-godkjent alarmstasjon. Med en fast lav månedspris og en moderne og fleksibel smarthus-plattform er Homely en boligalarm for folk flest. Alle sikkerhetsprodukter styres fra Homely-appen. Homely har inngått avtale med Storebrand forsikring som tilbyr og anbefaler løsningen til sine kunder.

Tipio en markedsplass for gruppekjøp som gir forbrukere de beste dealene på kjente produkter og tjenester. Vi endrer markedsdynamikken som kun er drevet av push, hvor forbrukerne endelig kan være med å påvirke og engasjere seg i en toveis dialog med marked. På den andre siden taper bedrifter over 80 milliarder dollar bare i år på de strenge reglene for GPDR/personvern og at ca 50% skrur av all sporings muligheter. Bransjen er i en enorm omstilling og er desperate etter alternative løsninger som hjelper de med dette. Det er her Tipio kommer inn å bidrar med økt salg, senke risikoen knyttet til markedsføring og tilbyr unike datainnsikter slik at bedriftene kan sende relevant og engasjerende budskap til dens kunder så markedet kan vinne sammen.

DigiUnity helps you train, network, communicate, collaborate, innovate, and more high margin and highly scalable SaaS company experiencing strong tractionCapital raised to date: 24 MNOK Total revenues to date: 4.5 MNOKRevenue 2019, YTD: NOK 800K (+100% growth)Recurring revenue level: NOK 50K/ month (MRR = +50% growth YTD)Non-recurring revenue level: 50-100K / month technology leading platform: Market verified, ready to scale sales team in place: 19 FTE´sActive Customers: 5 key customers Sales Pipeline: 20 new customers in the pipelineDistributors: 3 distribution/ resellers*Approx. and ballpark numbers. Learn more about us at www.digiunity.comIf any interest in DigiUnity, please contact Christian Teigland (CEO) at christian@digiunity.com or mobile at +47 950 61 5 61.

Klarna offer smoooth payments to 130.000 webshops and retailers across the globe. The company has 2500 employees spread over our 14 markets. Klarna Checkout is the main product, which offers merchants 1 integration, 1 agreement, 1 settlement for handling payments online and in stores. Klarna Norway AS has 15 (and increasing) employees who work at the 26th floor at Posthuset in Oslo.

Revolusjonen er i gang! Verden endrer seg i et forrykende tempo. Innovasjon og stadig fornyelse er viktigere enn noen gang for å beholde kundene. Moderne teknologi har raskere enn noensinne gjort at IT flytter seg nærmere forretning. Nå må beslutninger tas raskt og «fail fast» er nøkkelord. Revolusjonen har såvidt begynt og i Aboveit forstår vi effekten, virkemidlene og veien til målet.   Aboveit bygger broen mellom teknologi og forretning  - Ved å ta i bruk skyens kapabiliteter hjelper vi deg med å realisere forretningsverdi og å skape fortrinn i markedet. Vi er sikre på at morgendagens vinnere er de som får mest ut av plattformene og tjenestene i skyen. Vår tilnærming til transformasjon og digitalisering vil endre måten våre kunder tenker på sky. Vi er klare for reisen og til å løfte våre kunder til nye høyder. Velkommen til Aboveit - Vi kan hjelpe deg!

We bring Yoga- and Mindfulness services to companies in Oslo and Stavanger. A lot of prestigious companies are already enjoying our services, and our instructors are top-of-the-shelf and super-motivated! The Bedriftsyoga- team truly believe that ALL companies are benefited from having Yoga and Mindfulness at their workplace! It's a win-win for the employee, company and society ;D

Fakta leverer revisjon og utvidede regnskap- og rådgivningstjenester. Vi holder til i Solheimsviken 15B, Beddingen på Danmarksplass. Vår filosofi er å være et frittstående, lokalt selskap som leverer høy kvalitet med spisskompetanse som du kan stole på.I Fakta er vi opptatt av å ha nærhet til våre kunder på Vestlandet. Lokal forankring og uavhengighet gir oss i mange tilfeller muligheten til å tilby tjenester til en mer konkurransedyktig pris. Vi har oppdragsgivere innen et stort spekter av norsk næringsliv, og vi dekker behovene til mindre bedrifter så vel som større, børsnoterte selskaper.Etter betydelig vekst er vi nå ca 26 meget kompetente fagpersoner. For å holde tritt med utviklingen er våre tjenester i kontinuerlig utvikling og forbedring. Dette gjør oss til den aktive sparringspartneren du kan diskutere løsninger med og som gir deg gode råd når du trenger det.

7Mountains was founded in 2018 by a team of broadcast engineers and software developers in Norway. 7Mountains is part of Fonn Group and is headquartered in Media City Bergen, Norway. The majority owner is Rieber & Søn, a family-owned Norwegian investment company with an industrial legacy dating back to 1839. 7Mountains has founded Dina - a newsroom and storytelling solution changing how journalists work for story planning, creation and collaboration. Want to know more? Get in touch!

OptoScale supplies fish farmers with precise and relevant data empowering them to make decision that improve productivity, sustainability, and animal welfare. Our data informs fish farmers about how their production is going, by accurately measuring the size of fish, growth, welfare status, and parasite counting. Our head office is in Trondheim, Norway, and we deliver to our great customers around the world. We are continuously interested in hiring great people across most of our functions: HW development, AI/ML, electronics, sales and customer success.

Iterate is an ecosystem for digital innovation, and we like to describe ourselves as a company that builds companies. We contribute from A-Z when building, starting with creating concepts based on key insights to launching and improving products whilst living in the marketplace. We find the right team and work toward the company culture that enables us to deliver value to our customers quickly. The key to achieving this is reinvesting all our profits in the ideas of our employees, or selected entrepreneurs. Five years into this strategy, we own shares in fifteen ventures; all of which are showing promising results. Our 70 designers, developers, and product managers just moved into new locations in the center of Oslo. 
Close collaboration with our customers is key to our success. They provide domain know-how, and we provide tools, strategies, and experts. Together we uncover the best way that connects your strategy and idea with the market needs. Our goal is to achieve minimum risk and give our customers the best possible starting point for scaling, on their own, or in continued collaboration.

Oncoinvent AS is a privately held Norwegian company established in 2010. The company is committed to developing new innovative products to provide better treatment options to cancer patients. The innovations being developed by Oncoinvent AS are a result of the extensive experience with the development of radionuclide-based cancer treatments of two of the founders, Dr. Roy H. Larsen and Professor of clinical oncology Øyvind S. Bruland. Larsen and Bruland are the inventors of the first FDA and EMA-approved alpha-emitting pharmaceutical product Xofigo® (Bayer AG), as well as of the beta-emitting radio-immunotherapeutic product candidate Betalutin® (Nordic Nanovector ASA). Oncoinvent's lead product candidate, Radspherin®, is a novel alpha-emitting radioactive microsphere designed for the treatment of metastatic cancers in body cavities. Radspherin® has been shown to cause a significant reduction in tumor cell growth. It is anticipated that the product can potentially treat several forms of metastatic cancer. The first clinical indication for Radspherin® will be the treatment of peritoneal carcinomatosis. Clinical development will be conducted in collaboration with European and American clinical research centers.

Biozep is discovering and developing first-in-class drug products for the treatment of severe eye diseases which can lead to vision loss and where it is a high unmet medical need. Biozep has discovered novel drug substances based on bioactive lipids which modulate central pathways involved in the pathogenesis of eye diseases. Targets and biomarkers are identified based on a system biology approach combined with in-depth knowledge about bioactive lipids, their endogenous synthesis and mechanisms of action. Biozep has made a prototype drug product based on our lead compound for topical administration and the product will be tested in animal models in 2018. Our goal is to start clinical studies in 2020. Biozep is a company depending on both internal and external resources. Biozep has established its own laboratory in Oslo in order to do synthesis, purification, quality control and chemical development in-house. The biological testing of the drug substances is performed in collaboration with carefully selected contract research organizations both in Europe and the USA. In order to reach the market as fast as possible and to reduce risk, Biozep will seek strategic partnerships early in the drug development phase. Biozep seeks partners with complementary competence and with resources to conduct clinical trials and with market access. We are already in dialogue with potential partners and hope to sign an agreement in 2018-19.

Yetz is a new distribution platform for product lines such as insurance, electricity, telecom, and finance. At launch, we will offer both insurance and power. We utilize strong incentives towards our customers and partners to share the concept, by giving them an affiliate commission. Monthly payment is based on the turnover of customers they have referred. Two fully owned sister companies Yetz Strøm og Yetz Forsikring.

New drugs for treating diseases of Down syndrome. More than 1% of the global GDP is spent on nursing demented people, and the number requiring nursing will triple within 2050. The disease is progressive, leading to death. There is no current cure available, only symptomatic treatments. Individuals born with Down syndrome have a more than 10x risk of developing dementia as well as a host of other diseases including diabetes. Our drug target, DYRK1A is an enzyme found on chromosome 21, and is considered a key factor determining developmental and medical challenges faced by individuals with Down. The enzyme interacts with multiple biological mechanisms involved in Alzheimer’s and autoimmune diseases. Advanced drug designUsing advanced drug design technologies, we have designed a potent DYRK1A inhibitor drug, PST-900. A use and substance of matter patent have been applied for. The company is currently working on chemical Lead Optimisation with 8 full-time medicinal chemists contracted.Financing and milestonesThe Company raised NOK 5 million in 2015 and 8.8 MNOK in 2016/2017, matching non-dilutive research (BIA) and business grants (Innovation Norway). We demonstrated Proof of Principle in a model system for Alzheimer’s disease in 2Q2016. We have also demonstrated that our drug is capable of reversing diabetes in an animal model. Together with clinical and regulatory advisors, we have identified an important unmet need for a drug to treat newly diagnosed diabetes. We will use this indication to quickly progress to market and from there develop analogous drug molecules in Alzheimer’s disease, focused especially in Down syndrome. Funding soughtThe current funding round will raise 15+ MNOK to fund the progression to the final Development Candidate during 2018. Following this, further funding will be sought to perform toxicology/safety and Phase 1 clinical studies. A highly experienced teamThe team behind Pharmasum Therapeutics have broad, international pharmaceutical and biotechnology experience, and is supported by an excellent group of advisors. Anders Fugelli, Ph.D., CEO. John Sigurd Svendsen, Ph.D., CSO. Pauline Stewart-Long, Ph.D. Project Management. Henning Mork, CFO. Board of Directors: Andrew Parsons, PhD. Øystein Soug, MSc. Mark Treherne, PhD, John Sigurd Svendsen, PhD.

The Norgeskart app for iPhone and iPad is the most detailed map of Norway. Norgeskart is suitable for hikers, tourists, and city walkers. • Comprehensive, accurate maps of Norway are delivered by Kartverket • Download the map for offline use • GPS navigation with auto-rotating map and compass • Search for places and addresses • Detailed trails for hiking, biking, and walking • Accurate sea maps along the Norwegian coast • Ad-free experience